AIM IMMUNOTECH INC. Derivative Asset
AIM IMMUNOTECH INC. (AIM) had Derivative Asset of $7.17 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2023-11-14
- 2023-09-30: Derivative Asset $7.17M.
- 2023-06-30: Derivative Asset $7.36M.
- 2023-03-31: Derivative Asset $7.45M.
- 2022-12-31: Derivative Asset $7.14M.
| Period end | Derivative Asset |
|---|---|
| 2023-09-30 | $7.17M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $7.36M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.45M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.14M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $6.99M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.32M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $15.55M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $16.18M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $16.31M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $16.14M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $14.83M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $15.88M 10-K · filed 2022-03-31 |
| 2019-12-31 | $7.31M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |